Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of RNA m6A modification in nonalcoholic fatty liver disease. | Hepatol Commun | 2023 | 38345896 | PubTator, text mining | PubMed |
| Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks. | Front Immunol | 2023 | 38299148 | PubTator, text mining | PubMed |
| The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease. | Int J Mol Sci | 2023 | 38203666 | PubTator, text mining | PubMed |
| Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer's Disease. | Int J Mol Sci | 2023 | 38203185 | PubTator, text mining | PubMed |
| YTHDF1 in Tumor Cell Metabolism: An Updated Review. | Molecules | 2023 | 38202722 | PubTator, text mining | PubMed |
| Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review). | Cancers (Basel) | 2023 | 38201504 | PubTator, text mining | PubMed |
| miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. | Cells | 2023 | 38201290 | PubTator, text mining | PubMed |
| Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies. | Cells | 2023 | 38201270 | PubTator, text mining | PubMed |
| MrGPS: an m6A-related gene pair signature to predict the prognosis and immunological impact of glioma patients. | Brief Bioinform | 2023 | 38171932 | PubTator, text mining | PubMed |
| Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis. | J Hepatocell Carcinoma | 2023 | 38164510 | PubTator, text mining | PubMed |
| CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1. | Breast Cancer (Dove Med Press) | 2023 | 38164371 | PubTator, text mining | PubMed |
| The role of circRNAs in regulation of drug resistance in ovarian cancer. | Front Genet | 2023 | 38152652 | PubTator, text mining | PubMed |
| Epigenetic targeting of autophagy for cancer: DNA and RNA methylation. | Front Oncol | 2023 | 38148841 | PubTator, text mining | PubMed |
| Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer. | Genes (Basel) | 2023 | 38136994 | PubTator, text mining | PubMed |
| New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification. | Front Genet | 2023 | 38125749 | PubTator, text mining | PubMed |
| METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression. | Heliyon | 2023 | 38125436 | PubTator, text mining | PubMed |
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Novel insights into the regulatory role of N6-methyladenosine methylation modified autophagy in sepsis. | Aging (Albany NY) | 2023 | 38112620 | PubTator, text mining | PubMed |
| Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications. | Cell Commun Signal | 2023 | 38111040 | PubTator, text mining | PubMed |
LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway. | Cancer Cell Int | 2023 | 38110984 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=23